CDX2 and colorectal cancer: The antagonist influence of Oct4 on Cdx2 transcription in early embryonic development [77] was thus investigated based on the negative correlation reported between the expression of the two factors in colorectal cancer [78] but no modulation of OCT4 expression was observed in response to YAP1 ablation in HT29 cells.